We’re pleased to inform you that our Comprehensive Panel with Analyte Assurance™, along with the referenced panels below, will be updated for all orders effective September 29, 2025. The following analytes will be added: 5F-ADB Butanoic Acid Metabolite – Confirmed via...
By Laureen Marinetti, PhD, F-ABFT As part of its whole case approach, Axis Forensic Toxicology includes urine drug testing alongside blood testing in both the Comprehensive Panel with Analyte Assurance™ and Drugs of Abuse Panel. The standard urine screen typically...
By Kevin Shanks, M.S., D-ABFT-FT We have previously discussed both fentanyl and 4-ANPP in this blog (1-2), but briefly, fentanyl is a mu opioid receptor agonist that is used as both a pharmaceutical medication and as an illicit drug found on the street typically as a...
By Kevin Shanks, M.S., D-ABFT-FT As mentioned in several previous posts on this blog, novel psychoactive substances (NPS) are arranged into different families. Opioids, cannabinoids, stimulants, hallucinogens, and benzodiazepines are the main ones we encounter in...
By Kevin Shanks, M.S., D-ABFT-FT As we have discussed on this blog several times in the past, novel psychoactive substances (NPS) come in different varieties, which include cannabinoids, stimulants, opioids, benzodiazepines, and hallucinogens. One of Axis Forensic...
We’re excited to share that our Comprehensive Panel with Analyte Assurance™, as well as the below referenced panels, have been updated in all orders effective June 2nd, 2025. The analytes that have been added are as follows: ortho-Methylfentanyl – Confirmed via...
Axis is pleased to recognize the four Forensic Medicine Fellows that recently completed Axis’ toxicology rotation. The rotation is a week-long virtual program where participants reviewed many aspects of a modern forensic toxicology operation, including the...
At this year’s MATT meeting, Dr. Laureen Marinetti spoke to attendees about how to differentiate between ketamine used illicitly versus ketamine used medically. She also discussed the origin of medical and illicit ketamine. Ketamine was developed in 1962 for use as...
At this year’s MATT meeting, Stuart Kurtz spoke to attendees about the prevalence of nitazene analogs and the concentrations at which Axis detects them. We have previously discussed what nitazenes are in blog posts (see links below). As a reminder, they are potent mu...
